- STAT+: Roche ends Huntington’s gene-silencing programsARPA-H launches bespoke gene therapy push, Lilly and Novo to promote Bridge program, and more biotech news from The ReadoutSTAT · 16d ago↗ source
- STAT+: Pharmalittle: We’re reading about bigger drug discounts in Germany, drugmakers embracing secrecy, and moreGerman lawmakers passed a bill that would more than double the discount on branded medicines drugmakers must provide the governmentSTAT · 16d ago↗ source
- ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadership<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…